These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8636729)

  • 21. The incorporation of income and leisure in health state valuations when the measure is silent: an empirical inquiry into the sound of silence.
    Brouwer WB; Grootenboer S; Sendi P
    Med Decis Making; 2009; 29(4):503-12. PubMed ID: 19509120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A scale of valuations of states of illness: is there a social consensus?
    Rosser R; Kind P
    Int J Epidemiol; 1978 Dec; 7(4):347-58. PubMed ID: 744673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Comparison of Japan and U.K. SF-6D Health-State Valuations Using a Non-Parametric Bayesian Method.
    Kharroubi SA
    Appl Health Econ Health Policy; 2015 Aug; 13(4):409-20. PubMed ID: 25896874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility and reliability of a mailed questionnaire to obtain visual analogue scale valuations for health states defined by the Health Utilities Index Mark 3.
    Raat H; Bonsel GJ; Hoogeveen WC; Essink-Bot ML;
    Med Care; 2004 Jan; 42(1):13-8. PubMed ID: 14713735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health state valuations from the general public using the visual analogue scale.
    Gudex C; Dolan P; Kind P; Williams A
    Qual Life Res; 1996 Dec; 5(6):521-31. PubMed ID: 8993098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generalizability of valuations on health states collected with the EuroQolc-questionnaire.
    Essink-Bot ML; Stouthard ME; Bonsel GJ
    Health Econ; 1993 Oct; 2(3):237-46. PubMed ID: 8275169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Individual differences in the use of the response scale determine valuations of hypothetical health states: an empirical study.
    Essink-Bot ML; Stuifbergen MC; Meerding WJ; Looman CW; Bonsel GJ;
    BMC Health Serv Res; 2007 Apr; 7():62. PubMed ID: 17466068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How dead is dead? Qualitative findings from participants of combined traditional and lead-time time trade-off valuations.
    Al Sayah F; Mladenovic A; Gaebel K; Xie F; Johnson JA
    Qual Life Res; 2016 Jan; 25(1):35-43. PubMed ID: 26216584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health state valuations of patients and the general public analytically compared: a meta-analytical comparison of patient and population health state utilities.
    Peeters Y; Stiggelbout AM
    Value Health; 2010; 13(2):306-9. PubMed ID: 19744288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Duration of condition is unrelated to health-state valuation on the EuroQoL.
    Myers JA; McPherson KM; Taylor WJ; Weatherall M; McNaughton HK
    Clin Rehabil; 2003 Mar; 17(2):209-15. PubMed ID: 12625663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient versus general population health state valuations: a case study of non-specific low back pain.
    van Dongen JM; van denBerg B; Bekkering GE; van Tulder MW; Ostelo RWJG
    Qual Life Res; 2017 Jun; 26(6):1627-1633. PubMed ID: 28155048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of ill-health experience on the valuation of health.
    Badia X; Herdman M; Kind P
    Pharmacoeconomics; 1998 Jun; 13(6):687-96. PubMed ID: 10179704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. To what extent can we explain time trade-off values from other information about respondents?
    Dolan P; Roberts J
    Soc Sci Med; 2002 Mar; 54(6):919-29. PubMed ID: 11996025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Race and ethnic disparities in valuing health.
    Gaskin DJ; Frick KD
    Med Decis Making; 2008; 28(1):12-20. PubMed ID: 18263558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aggregating health state valuations.
    Dolan P
    J Health Serv Res Policy; 1997 Jul; 2(3):160-5; discussion 166-7. PubMed ID: 10180377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valuing the health state 'tinnitus': differences between patients and the general public.
    Happich M; von Lengerke T
    Hear Res; 2005 Sep; 207(1-2):50-8. PubMed ID: 15919164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Re-scaling social preference data: implications for modelling.
    Cleemput I; Kind P; Kesteloot K
    Eur J Health Econ; 2004 Dec; 5(4):290-8. PubMed ID: 15759169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are Health State Valuations from the General Public Biased? A Test of Health State Reference Dependency Using Self-assessed Health and an Efficient Discrete Choice Experiment.
    Jonker MF; Attema AE; Donkers B; Stolk EA; Versteegh MM
    Health Econ; 2017 Dec; 26(12):1534-1547. PubMed ID: 27790801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does the process of deliberation change individuals' health state valuations? An exploratory study using the person trade-off technique.
    Robinson S; Bryan S
    Value Health; 2013; 16(5):806-13. PubMed ID: 23947974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Sports activity as a form of increasing efficiency in rehabilitation of handicapped people].
    Sobiecka J
    Wiad Lek; 2002; 55 Suppl 1():454-8. PubMed ID: 15002284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.